Original language | English |
---|---|
Article number | 870474 |
Journal | Frontiers in Cardiovascular Medicine |
Volume | 9 |
DOIs | |
Publication status | Published - 10 Jun 2022 |
Bibliographical note
Funding Information:DL has received funding from Wellcome, the European Research Council (ERC Advanced grant and a Horizon 2020 grant), US National Institute of Health, Diabetes UK, Roche Diagnostics, and Medtronic Ltd., for research unrelated to that presented here. MC has received funding from Medtronic Ltd., for research unrelated to that presented. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding Information:
This work was supported by the British Heart Foundation Accelerator Award (AA/18/7/34219), which funds LC, and the Bristol National Institute of Health Research Biomedical Research Centre. LC, RC, and DL work in a unit that receives support from the University of Bristol and the United Kingdom Medical Research Council (MC_UU_00011/6). DL was supported by the BHF Chair in Cardiovascular Science and Clinical Epidemiology (CH/F/20/90003) and a National Institute of Health Research Senior Investigator (NF-0616-10102). MC was supported by the British Heart Foundation Chair in Congenital Heart Disease (CH/1/32804).
Publisher Copyright:
Copyright © 2022 Cocomello, Taylor, Caputo, Cornish and Lawlor.